Corrigendum to "A new pathogenic POLG variant" [Molecular Genetics and Metabolism Reports 32 (2022) 100890]

S Nicholas Russo^{1

2}, Ekta G Shah¹, William C Copeland³, Mary Kay Koenig^{1

2}

Affiliations

¹ The University of Texas McGovern Medical School, Department of Pediatrics, Division of Child and Adolescent Neurology, Houston, TX, USA.
² Center for the Treatment of Pediatric Neurodegenerative Disease, The University of Texas McGovern Medical School, Houston, TX, United States of America.
³ Mitochondrial DNA Replication Group, Genome Integrity and Structural Biology Laboratory, National Institute of Health, Research Triangle Park, NC, USA.

Published Erratum

S Nicholas Russo et al. Mol Genet Metab Rep. 2023.

. 2023 Jan 31:34:100958.

doi: 10.1016/j.ymgmr.2023.100958. eCollection 2023 Mar.

S Nicholas Russo^{1

2}, Ekta G Shah¹, William C Copeland³, Mary Kay Koenig^{1

2}

¹ The University of Texas McGovern Medical School, Department of Pediatrics, Division of Child and Adolescent Neurology, Houston, TX, USA.
² Center for the Treatment of Pediatric Neurodegenerative Disease, The University of Texas McGovern Medical School, Houston, TX, United States of America.
³ Mitochondrial DNA Replication Group, Genome Integrity and Structural Biology Laboratory, National Institute of Health, Research Triangle Park, NC, USA.

Abstract

[This corrects the article DOI: 10.1016/j.ymgmr.2022.100890.].

A new pathogenic POLG variant.
Nicholas Russo S, Shah EG, Copeland WC, Koenig MK. Nicholas Russo S, et al. Mol Genet Metab Rep. 2022 Jul 12;32:100890. doi: 10.1016/j.ymgmr.2022.100890. eCollection 2022 Sep. Mol Genet Metab Rep. 2022. PMID: 35860755 Free PMC article.